
Jonathan S. Lau
Examiner (ID: 8893, Phone: (571)270-3531 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1623, 1673 |
| Total Applications | 1249 |
| Issued Applications | 700 |
| Pending Applications | 107 |
| Abandoned Applications | 463 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19265317
[patent_doc_number] => 20240209016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => FLUORESCENT NUCLEOSIDE PHOSPHATES
[patent_app_type] => utility
[patent_app_number] => 18/555180
[patent_app_country] => US
[patent_app_date] => 2022-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14669
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18555180
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/555180 | FLUORESCENT NUCLEOSIDE PHOSPHATES | Apr 10, 2022 | Pending |
Array
(
[id] => 19279940
[patent_doc_number] => 20240216413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => THIONUCLEOSIDES AS ANTIVIRAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/285789
[patent_app_country] => US
[patent_app_date] => 2022-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18285789
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/285789 | THIONUCLEOSIDES AS ANTIVIRAL AGENTS | Apr 10, 2022 | Pending |
Array
(
[id] => 20824861
[patent_doc_number] => 12678403
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-07-14
[patent_title] => Pharmaceutical composition for preventing or treating obesity or non-alcoholic fatty liver containing Polygalin C as active ingredient
[patent_app_type] => utility
[patent_app_number] => 18/287015
[patent_app_country] => US
[patent_app_date] => 2022-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 0
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287015
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/287015 | Pharmaceutical composition for preventing or treating obesity or non-alcoholic fatty liver containing Polygalin C as active ingredient | Apr 7, 2022 | Issued |
Array
(
[id] => 19246776
[patent_doc_number] => 20240197760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => ACTIVATORS OF INTEGRATED STRESS RESPONSE PATHWAY FOR PROTECTION AGAINST FERROPTOSIS
[patent_app_type] => utility
[patent_app_number] => 18/285815
[patent_app_country] => US
[patent_app_date] => 2022-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20727
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18285815
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/285815 | ACTIVATORS OF INTEGRATED STRESS RESPONSE PATHWAY FOR PROTECTION AGAINST FERROPTOSIS | Apr 7, 2022 | Pending |
Array
(
[id] => 17749977
[patent_doc_number] => 20220228182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => STARCH-DERIVED CLATHRATE-FORMING COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/712349
[patent_app_country] => US
[patent_app_date] => 2022-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17712349
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/712349 | Starch-derived clathrate-forming compositions | Apr 3, 2022 | Issued |
Array
(
[id] => 17749978
[patent_doc_number] => 20220228183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => STARCH-DERIVED CLATHRATE-FORMING COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/712405
[patent_app_country] => US
[patent_app_date] => 2022-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17712405
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/712405 | Starch-derived clathrate-forming compositions | Apr 3, 2022 | Issued |
Array
(
[id] => 20212553
[patent_doc_number] => 12409187
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => PH regulating hydrogels that neutralize cancer cell environment acidosis and increase chemotherapy efficacy
[patent_app_type] => utility
[patent_app_number] => 17/710505
[patent_app_country] => US
[patent_app_date] => 2022-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 22
[patent_no_of_words] => 20237
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17710505
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/710505 | PH regulating hydrogels that neutralize cancer cell environment acidosis and increase chemotherapy efficacy | Mar 30, 2022 | Issued |
Array
(
[id] => 19310418
[patent_doc_number] => 12036212
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agent
[patent_app_type] => utility
[patent_app_number] => 17/705798
[patent_app_country] => US
[patent_app_date] => 2022-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 49
[patent_no_of_words] => 20436
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17705798
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/705798 | Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agent | Mar 27, 2022 | Issued |
Array
(
[id] => 18348219
[patent_doc_number] => 20230136330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => ANTIMICROBIAL AND/OR EPITHELIAL CELL GROWTH STIMULATING SUBSTANCE AND COMPOSITION AND TISSUE DRESSING MATERIAL
[patent_app_type] => utility
[patent_app_number] => 17/698086
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17698086
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/698086 | Antimicrobial and/or epithelial cell growth stimulating substance and composition and tissue dressing material | Mar 17, 2022 | Issued |
Array
(
[id] => 18739561
[patent_doc_number] => 20230348515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => NOVEL SOPHOROLIPID DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 18/016898
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5117
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18016898
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/016898 | NOVEL SOPHOROLIPID DERIVATIVE | Mar 17, 2022 | Abandoned |
Array
(
[id] => 19279934
[patent_doc_number] => 20240216407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => NOVEL POLYPHENOL COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/285600
[patent_app_country] => US
[patent_app_date] => 2022-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5588
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18285600
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/285600 | NOVEL POLYPHENOL COMPOUND | Mar 13, 2022 | Pending |
Array
(
[id] => 17937043
[patent_doc_number] => 11471475
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-10-18
[patent_title] => Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
[patent_app_type] => utility
[patent_app_number] => 17/689219
[patent_app_country] => US
[patent_app_date] => 2022-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15705
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17689219
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/689219 | Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery | Mar 7, 2022 | Issued |
Array
(
[id] => 17851960
[patent_doc_number] => 20220282002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => USE OF CATALYTIC ION EXCHANGE RESINS TO EFFECTIVELY DECOLORIZE POLYSACCHARIDES DERIVED FROM LIGNOCELLULOSIC BIOMASS
[patent_app_type] => utility
[patent_app_number] => 17/684856
[patent_app_country] => US
[patent_app_date] => 2022-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17684856
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/684856 | USE OF CATALYTIC ION EXCHANGE RESINS TO EFFECTIVELY DECOLORIZE POLYSACCHARIDES DERIVED FROM LIGNOCELLULOSIC BIOMASS | Mar 1, 2022 | Abandoned |
Array
(
[id] => 19142244
[patent_doc_number] => 20240141074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => Method of Producing Cellulose Carbamate
[patent_app_type] => utility
[patent_app_number] => 18/279078
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8243
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18279078
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/279078 | Method of producing cellulose carbamate | Feb 27, 2022 | Issued |
Array
(
[id] => 19096482
[patent_doc_number] => 20240115709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => ASSEMBLY OF ORGANIC SUPRAMOLECULAR VESSELS FOR CONTROLLED DRUG RELEASE
[patent_app_type] => utility
[patent_app_number] => 18/277195
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18043
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277195
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/277195 | ASSEMBLY OF ORGANIC SUPRAMOLECULAR VESSELS FOR CONTROLLED DRUG RELEASE | Feb 24, 2022 | Pending |
Array
(
[id] => 19691228
[patent_doc_number] => 20250009773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND VITAMIN B6
[patent_app_type] => utility
[patent_app_number] => 18/547932
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7740
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18547932
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/547932 | COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND VITAMIN B6 | Feb 22, 2022 | Pending |
Array
(
[id] => 18018846
[patent_doc_number] => 20220370345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => METHODS, AGENTS, AND DEVICES FOR LOCAL NEUROMODULATION OF AUTONOMIC NERVES
[patent_app_type] => utility
[patent_app_number] => 17/669778
[patent_app_country] => US
[patent_app_date] => 2022-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17669778
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/669778 | Methods, agents, and devices for local neuromodulation of autonomic nerves | Feb 10, 2022 | Issued |
Array
(
[id] => 18931012
[patent_doc_number] => 11883406
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Method for producing alginic acid-folic acid conjugate, alginic acid-folic acid conjugate produced thereby and pharmaceutical composition containing the same
[patent_app_type] => utility
[patent_app_number] => 17/590217
[patent_app_country] => US
[patent_app_date] => 2022-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 18
[patent_no_of_words] => 6814
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17590217
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/590217 | Method for producing alginic acid-folic acid conjugate, alginic acid-folic acid conjugate produced thereby and pharmaceutical composition containing the same | Jan 31, 2022 | Issued |
Array
(
[id] => 19150127
[patent_doc_number] => 11975017
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections
[patent_app_type] => utility
[patent_app_number] => 17/585651
[patent_app_country] => US
[patent_app_date] => 2022-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12181
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17585651
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/585651 | Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections | Jan 26, 2022 | Issued |
Array
(
[id] => 20911805
[patent_doc_number] => 12708640
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-08-18
[patent_title] => Synergistic nutritional compositions for treating vestibular associated neurodegenerative diseases
[patent_app_type] => utility
[patent_app_number] => 18/273749
[patent_app_country] => US
[patent_app_date] => 2022-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 6709
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273749
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/273749 | SYNERGISTIC NUTRITIONAL COMPOSITIONS FOR TREATING VESTIBULAR ASSOCIATED NEURODEGENERATIVE DISEASES | Jan 20, 2022 | Pending |